RankAlpha logo
Back to Rankings

DVA

DaVitaA
NYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
View Chart
Current thesis
The primary bull argument is that DaVita is still converting modest treatment growth and reimbursement tailwinds into strong cash generation, raised full-year guidance in the May 5, 2026 release, and is using large buybacks to amplify per-share results. IKC scale also offers a non-traditional growth lever.
Posture
Constructive
Lead driver
Momentum
What changed
3 setup hits (3d) with net bullish as of 2026-06-02.
What can break
Leverage remains material: the Q1 release showed about $10.0 billion of net debt and a 3.34x leverage ratio, leaving less room for execution misses even though covenant headroom remains.
Momentum
92
Value
68
Sentiment
36
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $160.00 · Bull $220.00 · Bear $130.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Bullish
Target $151.00
Why
Momentum92 · Δ7d -2.2
Value68 · Δ7d +0.4
Sentiment36 · Δ7d +6.6
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
92
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.2
Δ21d
+3.7
Value
68
32% active weight
Current posture
7d trendFlat
Δ7d
+0.4
Δ21d
+0.7
Sentiment
36
33% active weight
Current posture
7d trendImproving
Δ7d
+6.6
Δ21d
-1.3
Why this grade

Composite grade A. Momentum 92.4 / Value 68.2 / Sentiment 35.9

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$12.19B
Beta
0.99
Shares Out
70.6M
P/E (TTM)
11.7
P/S (TTM)
0.60
P/FCF (TTM)
6.22
Rev YoY
+4.8%
EPS YoY
-18.6%
Gross Margin
+32.0%
Op Margin
+15.3%
Net Debt
$8.6B
Current Ratio
1.36
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology